Synergistic activities between carbapenems and other antimicrobial agents against Acinetobacter baumannii including multidrug-resistant and extensively drug-resistant isolates

被引：47

作者：

Kiratisin, Pattarachai ^{[1
]}

Apisarnthanarak, Anucha ^{[2
]}

Kaewdaeng, Srirumpa ^{[1
]}

机构：

[1] Mahidol Univ, Siriraj Hosp, Fac Med, Dept Microbiol, Bangkok 10700, Thailand

[2] Thammasat Univ Hosp, Fac Med, Div Infect Dis, Pathum Thani 12120, Thailand

来源：

INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS | 2010年 / 36卷 / 03期

关键词：

Carbapenems; Combination therapy; Synergy; Acinetobacter baumannii; IN-VITRO ACTIVITIES; NONTRADITIONAL ANTIMICROBIALS; PSEUDOMONAS-AERUGINOSA; TIME-KILL; CHECKERBOARD; COMBINATION; SULBACTAM; MEROPENEM; STRAINS;

D O I：

10.1016/j.ijantimicag.2010.04.011

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

Treatment options for multidrug-resistant(MDR) and extensively drug-resistant (XDR) Acinetobacter baumannii have been seriously limited and may require combination antimicrobial therapy. In this study, we searched for synergistic activity between carbapenems (doripenem, imipenem and meropenem) and various non-traditional agents (cefoperazone/sulbactam, doxycycline, rifampicin, netilmicin and moxifloxacin) against 40 A. baumannii clinical isolates, including MDR and XDR isolates. The results showed that combination of each carbapenem with cefoperazone/sulbactam, based on the Etest method, demonstrated synergy more frequently (17.5-32.5%) than the other tested agents, which may suggest a role in combination therapy against highly resistant A. baumannii. (C) 2010 Elsevier B.V. and the International Society of Chemotherapy. All rights reserved.

引用

页码：243 / 246

页数：4

共 14 条

[1] Impact of multi-drug-resistant Acinetobacter baumannii on clinical outcomes [J].

Abbo, A. ;

Carmeli, Y. ;

Navon-Venezia, S. ;

Siegman-Igra, Y. ;

Schwaber, M. J. .

EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2007, 26 (11) :793-800

[2]

[Anonymous], 2009, M100S19 CLIN LAB STA

[3] In vitro activities of nontraditional antimicrobials against multiresistant Acinetobacter baumannii strains isolated in an intensive care unit outbreak [J].

Appleman, MD ;

Belzberg, H ;

Citron, DM ;

Heseltine, PNR ;

Yellin, AE ;

Murray, J ;

Berne, TV .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (04) :1035-1040

[4] Evaluation of antibiotic synergy against Acinetobacter baumannii:: a comparison with Etest, time-kill, and checkerboard methods [J].

Bonapace, CR ;

White, RL ;

Friedrich, LV ;

Bosso, JA .

DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2000, 38 (01) :43-50

[5]

Eliopoulos G.M. e., 1996, Antibiotics in laboratory medicine

[6] Pandrug resistance (PDR), extensive drug resistance (XDR), and multidrug resistance (MDR) among gram-negative bacilli: Need for international harmonization in terminology [J].

Falagas, Matthew E. ;

Karageorgopoulos, Drosos E. .

CLINICAL INFECTIOUS DISEASES, 2008, 46 (07) :1121-1122

[7] Synergistic activities of moxifloxacin combined with piperacillin-tazobactam or cefepime against Klebsiella pneumoniae, Enterobacter cloacae, and Acinetobacter baumannii clinical isolates [J].

Jung, R ;

Husain, M ;

Choi, MK ;

Fish, DN .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (03) :1055-1057

[8] In vitro synergy test of meropenem and sulbactam against clinical isolates of Acinetobacter baumannii [J].

Kiffer, CRV ;

Sampaio, JLM ;

Sinto, S ;

Oplustil, CP ;

Koga, PCM ;

Arruda, AC ;

Turner, PJ ;

Mendes, C .

DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2005, 52 (04) :317-322

[9] Combination carbapenem-sulbactam therapy for critically ill patients with multidrug-resistant Acinetobacter baumannii bacteremia:: Four case reports and an in vitro combination synergy study [J].

Lee, Nan-Yao ;

Wang, Chun-Lung ;

Chuang, Yin-Ching ;

Yu, Wen-Liang ;

Lee, Hsin-Chun ;

Chang, Chia-Ming ;

Wang, Li-Rong ;

Ko, Wen-Chien .

PHARMACOTHERAPY, 2007, 27 (11) :1506-1511

[10] Emergence and widespread dissemination of OXA-23,-24/40 and-58 carbapenemases among Acinetobacter spp. in Asia-Pacific nations: report from the SENTRY Surveillance Program [J].

Mendes, Rodrigo E. ;

Bell, Jan M. ;

Turnidge, John D. ;

Castanheira, Mariana ;

Jones, Ronald N. .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2009, 63 (01) :55-59

← 1 2 →